Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBCN.L Regulatory News (BCN)

  • There is currently no data for BCN

Form 8 (OPD) Bacanora Lithium plc - Amendment

7 Sep 2021 14:22

RNS Number : 0135L
Bacanora Lithium PLC
07 September 2021
 

The following amendment has been made to the Form 8 (OPD) announcement released on 19/05/2021 under RNS 1440Z.

 

An amendment has been made to section 3(a) to display the correct interest held by Eileen Carr. All other details remain unchanged. The full amended text is shown below.

 

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Bacanora Lithium plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bacanora Lithium plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

6 September 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 10p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

0

NIL

0

(2) Cash-settled derivatives:

 

NIL

0

NIL

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

0

NIL

0

 

TOTAL:

NIL

0

NIL

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests of directors of Bacanora Lithium plc in Bacanora Lithium plc's ordinary shares of 10 pence each

 

Name

Number of ordinary shares of 10 pence each

Percentage of total issued share capital (%) (excluding any shares held under option)

Mark Hohnen

3,012,547

0.91%

Peter Secker

336,250

0.10%

Jamie Strauss

102,857

0.03%

Eileen Carr

88,888

0.02%

 

(b) Details of awards granted to the directors of Bacanora Lithium plc over Bacanora Lithium plc's ordinary shares of 10 pence each

 

Name

Number of ordinary shares of 10 pence each

Percentage of total issued share capital (%) (excluding any shares held under option)

Grant date

Exercise price (p)

Expiry date

Peter Secker

205,800

0.06%

28 Oct'19

33.25p

27 Oct'22

Peter Secker

215,488

0.06%

2 Oct'20

24.40p

1 Oct'23

Mark Hohnen

151,439

0.05%

28 Oct'19

33.25p

27 Oct'22

Mark Hohnen

179,501

0.05%

2 Oct'20

24.40p

1 Oct'23

 

(c) Details of RSUs granted to the directors of Bacanora Lithium plc over Bacanora Lithium plc's ordinary shares of 10 pence each

 

Name

Number of ordinary shares of 10 pence each

Percentage of total issued share capital (%) (excluding any shares held under option)

Grant date

Vesting date

Peter Secker

278,546

0.08%

28 Oct'19

27 Oct'22

Peter Secker

117,420

0.04%

2 Oct'20

1 Oct'23

Mark Hohnen

204,970

0.06%

28 Oct'19

27 Oct'22

Mark Hohnen

97,811

0.03%

2 Oct'20

1 Oct'23

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

7 September 2021

Contact name:

Peter Secker

Telephone number:

info@bacanoralithium.com

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEXDLFBFKLBBBQ
Date   Source Headline
30th Jun 20219:44 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
30th Jun 20219:15 amRNSForm 8.5 (EPT/RI)
29th Jun 202110:21 amRNSForm 8.3 - Bacanora Lithium plc
29th Jun 20219:25 amRNSForm 8.5 (EPT/RI)
29th Jun 20219:13 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
28th Jun 20212:03 pmRNSForm 8.3 - Bacanora Lithium plc
28th Jun 202112:30 pmRNSGanfeng Extraordinary General Meeting
28th Jun 20219:19 amRNSForm 8.5 (EPT/RI)
28th Jun 20219:05 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
25th Jun 20214:39 pmRNSForm 8.3 - Bacanora Lithium plc
25th Jun 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
25th Jun 202110:27 amRNSHolding(s) in Company
24th Jun 202111:07 amRNSForm 8.5 (EPT/RI)
24th Jun 202110:00 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
23rd Jun 202110:18 amRNSForm 8.5 (EPT/RI)
23rd Jun 20218:21 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
23rd Jun 20217:00 amRNSAGM update and remote access
22nd Jun 202112:20 pmRNSUpdate on Zinnwald Lithium, Sonora & debt facility
22nd Jun 202110:22 amRNSForm 8.5 (EPT/RI)
22nd Jun 20219:18 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
21st Jun 202110:10 amRNSForm 8.5 (EPT/RI)
21st Jun 20218:08 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
18th Jun 202110:31 amRNSForm 8.5 (EPT/RI)
18th Jun 20218:36 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
17th Jun 20219:20 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
17th Jun 20219:11 amRNSForm 8.5 (EPT/RI)
16th Jun 202110:38 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
16th Jun 20219:36 amPRNForm 8.3 - Bacanora Lithium plc
16th Jun 20218:33 amRNSForm 8.5 (EPT/RI)
15th Jun 20219:36 amRNSForm 8.5 (EPT/RI)
15th Jun 20218:56 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
14th Jun 20219:50 amRNSForm 8.5 (EPT/RI)
14th Jun 20218:16 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
11th Jun 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
11th Jun 20219:40 amRNSForm 8.5 (EPT/RI)
11th Jun 20219:23 amRNSForm 8.5 (EPT/RI)
10th Jun 202112:00 pmRNSForm 8.5 (EPT/RI)
10th Jun 202111:30 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
10th Jun 202111:24 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
9th Jun 20219:52 amRNSForm 8.5 (EPT/RI)
9th Jun 20219:13 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
8th Jun 202111:13 amRNSForm 8.5 (EPT/RI)
8th Jun 20219:27 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
7th Jun 202111:32 amRNSForm 8.5 (EPT/RI)
7th Jun 20219:53 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
4th Jun 202111:45 amRNSForm 8.5 (EPT/RI)
4th Jun 20219:11 amRNSForm 8.5 (EPT/RI)
4th Jun 20219:03 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
3rd Jun 202110:09 amRNSPUSU extension
3rd Jun 20219:05 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.